Confronting cancer in the Caribbean, through community, information and more than a little ‘bad mind’ and humour.
…
continue reading
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and sta ...
…
continue reading
1
Neoadjuvant Exercise Therapy in Prostate Cancer
19:01
19:01
Play later
Play later
Lists
Like
Liked
19:01
Interview with Lee W. Jones, PhD, author of Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized Controlled Trial. Hosted by Vivek Subbiah, MD. Related Content: Neoadjuvant Exercise Therapy in Prostate Cancer
…
continue reading
1
Endometrial Thickness as Diagnostic Triage for Endometrial Cancer in Black Individuals
15:04
15:04
Play later
Play later
Lists
Like
Liked
15:04
Interview with Kemi M. Doll, MD, MSCR, author of Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals. Hosted by Vivek Subbiah, MD. Related Content: Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals
…
continue reading
1
T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
19:57
19:57
Play later
Play later
Lists
Like
Liked
19:57
Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD. Related Content: T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
…
continue reading
1
Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time
25:53
25:53
Play later
Play later
Lists
Like
Liked
25:53
Interview with Tobias Janowitz, MD, PhD, and Karen Winkfield, MD, PhD, authors of Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time. Hosted by Vivek Subbiah, MD. Related Content: Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time…
…
continue reading
1
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer
14:26
14:26
Play later
Play later
Lists
Like
Liked
14:26
Interview with José P. Leone, MD, author of Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. Hosted by Nora L. (Mary) Disis, MD. Related Content: Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer
…
continue reading
1
Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US
17:31
17:31
Play later
Play later
Lists
Like
Liked
17:31
Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD. Related Content: Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US
…
continue reading
1
Atezolizumab in Combination With Carboplatin in Metastatic TNBC
18:18
18:18
Play later
Play later
Lists
Like
Liked
18:18
Interview with Jennifer A. Pietenpol, PhD, Brian D. Lehmann, PhD, and Vandana G. Abramson, MD, authors of Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial. Hosted by Mary L. (Nora) Disis, MD. Related Content: Atezolizumab in …
…
continue reading
1
Updates in the Treatment of Patients with EGFR Exon 20 Insertion Mutation NSCLC
10:17
10:17
Play later
Play later
Lists
Like
Liked
10:17
This podcast provides an overview of current and emerging data available in the treatment of EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer, including updates from ESMO 2023. Key takeaways:- Review treatment options for EGFR Exon 20 Insertion Mutations in NSCLC - Review updated clinical data from ELCC and ESMO 2023 - Gain an understandi…
…
continue reading
1
Shorter-Course Radiotherapy for Prostate Cancer
15:14
15:14
Play later
Play later
Lists
Like
Liked
15:14
Interview with Daniel E. Spratt, MD, author of Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer. Hosted by Jack West, MD. Related Content: Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer
…
continue reading
1
Sentinel Lymph Node Biopsy vs No Axillary Procedure in Small Node-Negative Breast Cancer
19:02
19:02
Play later
Play later
Lists
Like
Liked
19:02
Interview with Oreste Davide Gentilini, MD, author of Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients Wit…
…
continue reading
1
A Geospatial Analysis of Disparities in Access to Oncofertility Services
23:12
23:12
Play later
Play later
Lists
Like
Liked
23:12
Interview with Kara N. Goldman, MD, author of A Geospatial Analysis of Disparities in Access to Oncofertility Services. Hosted by Jack West, MD. Related Content: A Geospatial Analysis of Disparities in Access to Oncofertility Services
…
continue reading
1
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases
16:29
16:29
Play later
Play later
Lists
Like
Liked
16:29
Interview with Sean P. Pitroda, MD, author of Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Integrated Clinical-Molecular Classification of Colorectal Liver Metastases…
…
continue reading
1
US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020
17:16
17:16
Play later
Play later
Lists
Like
Liked
17:16
Interview with Sophia C. Kamran, MD, author of US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020. Hosted by Jack West, MD. Related Content: US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020
…
continue reading
1
Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer
15:07
15:07
Play later
Play later
Lists
Like
Liked
15:07
Interview with Robert W. Holloway, MD, and Sarfraz Ahmad, PhD, authors of Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial. Hosted by Jack West, MD. Related Content: Clinical Activi…
…
continue reading
1
Radiosurgery of Spine Metastasis—NRG/RTOG 0631 RCT Final Results
14:15
14:15
Play later
Play later
Lists
Like
Liked
14:15
Interview with Samuel Ryu, MD, author of Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of t…
…
continue reading
1
Pathologic Complete Response and Clinical Outcomes in Soft Tissue Sarcoma
14:03
14:03
Play later
Play later
Lists
Like
Liked
14:03
Interview with Dian Wang, MD, author of Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials. Hosted by Jack West, MD. Related Content: Pathologic Complete Response and Clinical Outcomes i…
…
continue reading
1
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma
16:40
16:40
Play later
Play later
Lists
Like
Liked
16:40
Interview with Laura A. Bolte, MSc, Geke A. P. Hospers, MD, PhD, and Rinse K. Weersma, MD, PhD, authors of Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma. Hosted by Jack West, MD. Related Content: Association of a Mediterranean Diet With Outcomes for Patients Treated With…
…
continue reading
1
Adoption of Innovative Therapies Across Oncology Practices
21:08
21:08
Play later
Play later
Lists
Like
Liked
21:08
Interview with Nancy L. Keating, MD, MPH, author of Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy. Hosted by Jack West, MD. Related Content: Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy
…
continue reading
1
Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy
18:37
18:37
Play later
Play later
Lists
Like
Liked
18:37
Interview with Marco Del Chiaro, MD, PhD, author of Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. Hosted by Jack West, MD. Related Content: Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemot…
…
continue reading
1
Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma
18:28
18:28
Play later
Play later
Lists
Like
Liked
18:28
Interview with Linda M. Liau, MD, PhD, author of Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. Hosted by Jack West, MD. Related Content: Association of Autologous Tumor Lysat…
…
continue reading
1
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
12:16
12:16
Play later
Play later
Lists
Like
Liked
12:16
Interview with Olivier J. van Not, MD, and Karijn P. M. Suijkerbuijk, MD, PhD, authors of Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma. Hosted by Jack West, MD. Related Content: Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma…
…
continue reading
1
Prostate-Specific Antigen Screening Rates and Metastatic Prostate Cancer Incidence in the VHA
16:36
16:36
Play later
Play later
Lists
Like
Liked
16:36
Interview with Brent S. Rose, MD, author of Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities. Hosted by Jack West, MD. Related Content: Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incid…
…
continue reading
1
Therapy and Survival Patterns in Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy
15:26
15:26
Play later
Play later
Lists
Like
Liked
15:26
Interview with Hagen F. Kennecke, MD, author of Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy. Hosted by Jack West, MD.
…
continue reading
1
Global Association of COVID-19 Pandemic Measures With Cancer Screening
12:53
12:53
Play later
Play later
Lists
Like
Liked
12:53
Interview with Paolo Boffetta, MD, author of Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis. Hosted by Jack West, MD.
…
continue reading
1
A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief
22:07
22:07
Play later
Play later
Lists
Like
Liked
22:07
In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public he…
…
continue reading
1
High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade
19:09
19:09
Play later
Play later
Lists
Like
Liked
19:09
Interview with Mark M. Awad, MD, PhD, author of Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Hosted by Jack West, MD.
…
continue reading
1
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
14:06
14:06
Play later
Play later
Lists
Like
Liked
14:06
Interview with Lars Björnebo, MSc, and Anna Lantz, MD, PhD, authors of Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality. Hosted by Jack West, MD.
…
continue reading
1
Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
23:31
23:31
Play later
Play later
Lists
Like
Liked
23:31
Interview with David Anthony Palma, MD, PhD, and Anthony C. Nichols, MD, authors of Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial Hosted by Jack West, MD.…
…
continue reading
1
Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer
20:09
20:09
Play later
Play later
Lists
Like
Liked
20:09
Interview with Kenneth L. Kehl, MD, MPH, author of Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216). Hosted by Jack West, MD.
…
continue reading
1
Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer
15:22
15:22
Play later
Play later
Lists
Like
Liked
15:22
Interview with Ruth C. Carlos, MD and Gelareh Sadigh, MD, authors of Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial. Hosted by Jack West, MD.…
…
continue reading
1
Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy
18:16
18:16
Play later
Play later
Lists
Like
Liked
18:16
Interview with Laurent Dercle, MD, PhD, author of Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis. Hosted by Jack West, MD.
…
continue reading
1
Fork Cancer! Episode 4 - Stage 4 Metastatic Breast Cancer Outlier Pearl Balgaroo Talks Survival 15 Years Later...
1:00:55
1:00:55
Play later
Play later
Lists
Like
Liked
1:00:55
Diagnosed initially in 2006 with metastatic stage 4, PR+ breast cancer and then again in 2020 with triple negative breast cancer, Pearl continues to defy the statistics with focus and tenacity. 15 years after her diagnosis, she is with us to talk survival.By Sarita/Pearl Balgaroo
…
continue reading
1
Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
22:38
22:38
Play later
Play later
Lists
Like
Liked
22:38
Interview with Robert J. Motzer, MD, author of Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma. Hosted by Jack West, MD.
…
continue reading
1
Fork Cancer! Episode 3 - A Husband Speaks - A Conversation with Curtis Khan
49:12
49:12
Play later
Play later
Lists
Like
Liked
49:12
Curtis's wife Alexa, was diagnosed with Stage 4 stomach cancer in 2015, and given, at best, a year to live. Alexa recently passed away, 6 and a half years after her diagnosis. Curtis was her support and self-appointed caregiver, and he shares Alexa's story, as well as his thoughts and feelings both during her journey and after her death.…
…
continue reading
1
Fork Cancer! Episode 2 - Stage 3b HER2+ Breast Cancer, a Uniboob, Menopause and Her Fork Cancer Mentality - A Conversation with Sarita Rampersad
43:56
43:56
Play later
Play later
Lists
Like
Liked
43:56
Sarita talks with friends about her diagnosis and treatment for Stage 3B Her2+ breast cancer, including coming to terms with her uniboob, menopause and her fork cancer mentality. Websites mentioned in this episode - http://www.saritasaysforkcancer.com http://www.ncbi.nim..nih.gov http://www.pubmed.com http://www.researchgate.net http://www.mskcc.or…
…
continue reading
1
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer
23:56
23:56
Play later
Play later
Lists
Like
Liked
23:56
Interview with Emmanouil Fokas, MD, DPhil, author of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. Hosted by Jack West, MD.
…
continue reading
1
Fork Cancer! Confronting Metastatic Breast Cancer De Novo - a Conversation with Tracy Hutchinson Wallace
58:46
58:46
Play later
Play later
Lists
Like
Liked
58:46
Tracy fearlessly and honestly discusses her initial diagnosis with metastatic breast cancer de novo (de novo means being diagnosed with cancer for the first time), talking about navigating her journey while parenting two young boys, living with intention, and planning for her end of life and her sons’ well being. Website mentioned in this episode -…
…
continue reading
1
Clinical Outcomes and Toxic Effects of Single-Agent ICI Treatment Among Geriatric Patients With Cancer
21:19
21:19
Play later
Play later
Lists
Like
Liked
21:19
Interview with Abdul Rafeh Naqash, MD, and Caroline A. Nebhan, MD, PhD, authors of Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study. Hosted by Jack West, MD.
…
continue reading
Presenter: Philip R. Muskin MD, MA, DLFAPA Professor of Psychiatry Columbia University Irving Medical Center Senior Consultant in Consultation-Liaison Psychiatry New York-Presbyterian Hospital New York, NY Chronic medical illnesses such as cancer are characterized by a notably increased prevalence of depression. Furthermore, several challenges may …
…
continue reading
Presenter: Hope S. Rugo MD Professor of Medicine University of California San Francisco Comprehensive Cancer Center TNBC comprises approximately 15% of newly diagnosed breast cancer cases and is defined by being estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor receptor 2-negative. This breast cancer subt…
…
continue reading
1
Using Available Evidence and Guidelines for Managing an Evolving AML Treatment Paradigm
27:20
27:20
Play later
Play later
Lists
Like
Liked
27:20
Presenter: Gail J. Roboz MD Professor of Medicine Director, Clinical and Translational Leukemia Program Weill Medical College of Cornell University New York-Presbyterian Hospital New York, New York, United States This brief program will begin with a review of NCCN Guidelines® Recommendations for the treatment of AML in individuals 60 years of age o…
…
continue reading
1
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-Risk Breast Cancer
34:49
34:49
Play later
Play later
Lists
Like
Liked
34:49
Interview with Laura J. Esserman, MD, and W. Fraser Symmans, MD, authors of Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial
…
continue reading
1
Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With NSCLC
16:52
16:52
Play later
Play later
Lists
Like
Liked
16:52
Interview with Puneeth Iyengar, MD, PhD, author of Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non–Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial
…
continue reading
1
Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer
16:31
16:31
Play later
Play later
Lists
Like
Liked
16:31
Interview with Carsten Finke, MD, and Frederik Bartels, MD, authors of Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer
…
continue reading
1
Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in ERBB2-Positive Breast Cancer
13:01
13:01
Play later
Play later
Lists
Like
Liked
13:01
Interview with Thomas Hatschek, MD, PhD, author of Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial
…
continue reading
1
Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases
19:04
19:04
Play later
Play later
Lists
Like
Liked
19:04
Interview with David R. Raleigh, MD, PhD, and William C. Chen, MD, authors of Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases: A Systematic Review and Meta-analysis
…
continue reading
1
Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC
15:06
15:06
Play later
Play later
Lists
Like
Liked
15:06
Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
…
continue reading
1
Chronic Toxic Effects Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma
17:39
17:39
Play later
Play later
Lists
Like
Liked
17:39
Interview with Douglas B. Johnson, MD, author of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma
…
continue reading
1
Anti–PD-1 Immunotherapy in Microsatellite-Stable Tumors With 10 or More Mutations per Megabase
29:39
29:39
Play later
Play later
Lists
Like
Liked
29:39
Interview with Luc GT Morris, MD MSc, author of Response Rates to Anti–PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase
…
continue reading
1
Virtual Care Across a Tertiary Cancer Center During COVID-19
23:45
23:45
Play later
Play later
Lists
Like
Liked
23:45
Interview with Alejandro Berlin, MD, MSc, author of Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19
…
continue reading